ReP USP - Resultado da busca

Artigo de periodico
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults (2023)
Albuquerque, João; Medeiros, Ana Margarida; Alves, Ana Catarina; Lepski, Cinthia Elim Jannes ; Mancina, Rosellina M; Pavanello, Chiara; Chora, Joana Rita; Mombelli, Giuliana; Calabresi, Laura; Pereira, Alexandre da Costa ; Krieger, Jose Eduardo
Fonte: Atherosclerosis. Unidade: FM
Assuntos: HIPERCOLESTEROLEMIA, APRENDIZADO COMPUTACIONAL, REGRESSÃO LOGÍSTICA, REGRESSÃO LOGÍSTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBUQUERQUE, João et al. Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults. Atherosclerosis, v. 383, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57368. Acesso em: 09 nov. 2024.
APA
Albuquerque, J., Medeiros, A. M., Alves, A. C., Lepski, C. E. J., Mancina, R. M., Pavanello, C., et al. (2023). Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults. Atherosclerosis, 383. doi:10.1016/j.atherosclerosis.2023.117314
NLM
Albuquerque J, Medeiros AM, Alves AC, Lepski CEJ, Mancina RM, Pavanello C, Chora JR, Mombelli G, Calabresi L, Pereira A da C, Krieger JE. Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults [Internet]. Atherosclerosis. 2023 ; 383[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57368
Vancouver
Albuquerque J, Medeiros AM, Alves AC, Lepski CEJ, Mancina RM, Pavanello C, Chora JR, Mombelli G, Calabresi L, Pereira A da C, Krieger JE. Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults [Internet]. Atherosclerosis. 2023 ; 383[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57368
Artigo de periodico
Cardiovascular disease onset in old people with severe hypercholesterolemia (2023)
Coutinho, Elaine R; Miname, Marcio H; Rocha, Viviane Z; Bittencourt, Marcio S; Jannes, Cinthia E; Krieger, Jose Eduardo ; Pereira, Alexandre C; Santos Filho, Raul Dias dos
Fonte: Atherosclerosis. Unidade: FM
Assuntos: HIPERCOLESTEROLEMIA, FATORES DE RISCO, ARTERIOSCLEROSE, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTINHO, Elaine R et al. Cardiovascular disease onset in old people with severe hypercholesterolemia. Atherosclerosis, v. 365, p. 9-14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52911. Acesso em: 09 nov. 2024.
APA
Coutinho, E. R., Miname, M. H., Rocha, V. Z., Bittencourt, M. S., Jannes, C. E., Krieger, J. E., et al. (2023). Cardiovascular disease onset in old people with severe hypercholesterolemia. Atherosclerosis, 365, 9-14. doi:10.1016/j.atherosclerosis.2022.12.007
NLM
Coutinho ER, Miname MH, Rocha VZ, Bittencourt MS, Jannes CE, Krieger JE, Pereira AC, Santos Filho RD dos. Cardiovascular disease onset in old people with severe hypercholesterolemia [Internet]. Atherosclerosis. 2023 ; 365 9-14.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52911
Vancouver
Coutinho ER, Miname MH, Rocha VZ, Bittencourt MS, Jannes CE, Krieger JE, Pereira AC, Santos Filho RD dos. Cardiovascular disease onset in old people with severe hypercholesterolemia [Internet]. Atherosclerosis. 2023 ; 365 9-14.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52911
Trabalho de evento-resumo periodico
Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 (2021)
Leão, Matheus de Castro; Pohlmann, Adriana Raffin ; Farsky, Sandra Helena Poliselli ; Broering, Milena Fronza; Castro, Inar Alves de ; Guterres, Sílvia Stanisçuaski
Fonte: Atherosclerosis. Nome do evento: Congress European Atherosclerosis Society/EAS. Unidade: FCF
Assuntos: ARTERIOSCLEROSE, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Matheus de Castro et al. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf? Acesso em: 09 nov. 2024. , 2021
APA
Leão, M. de C., Pohlmann, A. R., Farsky, S. H. P., Broering, M. F., Castro, I. A. de, & Guterres, S. S. (2021). Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
NLM
Leão M de C, Pohlmann AR, Farsky SHP, Broering MF, Castro IA de, Guterres SS. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 [Internet]. Atherosclerosis. 2021 ; 331 e73 res. P053.[citado 2024 nov. 09 ] Available from: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
Vancouver
Leão M de C, Pohlmann AR, Farsky SHP, Broering MF, Castro IA de, Guterres SS. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 [Internet]. Atherosclerosis. 2021 ; 331 e73 res. P053.[citado 2024 nov. 09 ] Available from: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
Artigo de periodico
Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk (2021)
Ma, Feng; Darabi, Maryam; Lhomme, Marie; Tubeuf, Emilie; Canicio, Aurelie; Brerault, Jean; Medadje, Narcisse; Rached, Fabiana; Serrano Junior, Carlos Vicente ; Santos Filho, Raul Dias dos
Fonte: Atherosclerosis. Unidade: FM
Assuntos: LIPOPROTEÍNAS HDL, COLESTEROL, FATORES DE RISCO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MA, Feng et al. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk. Atherosclerosis, v. 324, p. 01-08, 2021Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53856. Acesso em: 09 nov. 2024.
APA
Ma, F., Darabi, M., Lhomme, M., Tubeuf, E., Canicio, A., Brerault, J., et al. (2021). Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk. Atherosclerosis, 324, 01-08. doi:10.1016/j.atherosclerosis.2021.03.002
NLM
Ma F, Darabi M, Lhomme M, Tubeuf E, Canicio A, Brerault J, Medadje N, Rached F, Serrano Junior CV, Santos Filho RD dos. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk [Internet]. Atherosclerosis. 2021 ; 324 01-08.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53856
Vancouver
Ma F, Darabi M, Lhomme M, Tubeuf E, Canicio A, Brerault J, Medadje N, Rached F, Serrano Junior CV, Santos Filho RD dos. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk [Internet]. Atherosclerosis. 2021 ; 324 01-08.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53856
Artigo de periodico
Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice (2021)
Bochi, Ana Paula Garcia ; Ferreira, Guilherme da Silva ; Pinto, Paula Ramos ; Bianco, Vanessa Del; Rodrigues, Letícia Gomes ; Trevisani, M. S.; Bispo, K. C. S.; Capelozzi, Vera Luiza ; Nakandakare, Edna Regina ; Machado, Ubiratan Fabres ; Teodoro, W. R.; Passarelli, Marisa ; Catanozi, Sergio
Fonte: Atherosclerosis. Unidades: FM, ICB
Assuntos: FISIOLOGIA, TREINAMENTO AERÓBIO, RESISTÊNCIA À INSULINA, GORDURAS, DIETA ANIMAL, DIETA COM RESTRIÇÃO DE GORDURAS, SÓDIO, PRESSÃO SANGUÍNEA, CAMUNDONGOS, LIPÍDEOS, PRESSÃO SANGUÍNEA, ANGIOTENSINA II
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCHI, Ana Paula Garcia et al. Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice. Atherosclerosis, v. 331, p. e102-e103, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2021.06.302. Acesso em: 09 nov. 2024.
APA
Bochi, A. P. G., Ferreira, G. da S., Pinto, P. R., Bianco, V. D., Rodrigues, L. G., Trevisani, M. S., et al. (2021). Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice. Atherosclerosis, 331, e102-e103. doi:10.1016/j.atherosclerosis.2021.06.302
NLM
Bochi APG, Ferreira G da S, Pinto PR, Bianco VD, Rodrigues LG, Trevisani MS, Bispo KCS, Capelozzi VL, Nakandakare ER, Machado UF, Teodoro WR, Passarelli M, Catanozi S. Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice [Internet]. Atherosclerosis. 2021 ; 331 e102-e103.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.302
Vancouver
Bochi APG, Ferreira G da S, Pinto PR, Bianco VD, Rodrigues LG, Trevisani MS, Bispo KCS, Capelozzi VL, Nakandakare ER, Machado UF, Teodoro WR, Passarelli M, Catanozi S. Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice [Internet]. Atherosclerosis. 2021 ; 331 e102-e103.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.302
Trabalho de evento-resumo periodico
Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans (2021)
Santana, Tamires Miranda ; Ogawa, Lucas Yuiiti; Rogero, Marcelo Macedo ; Barroso, Lucia Pereira; Castro, Inar Alves de
Fonte: Atherosclerosis. Nome do evento: Congress European Atherosclerosis Society/EAS. Unidades: FSP, IME, FCF
Assuntos: BIOMARCADORES, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Tamires Miranda et al. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans. Atherosclerosis. Clare: Faculdade de Saúde Pública, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2021.06.768. Acesso em: 09 nov. 2024. , 2021
APA
Santana, T. M., Ogawa, L. Y., Rogero, M. M., Barroso, L. P., & Castro, I. A. de. (2021). Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans. Atherosclerosis. Clare: Faculdade de Saúde Pública, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2021.06.768
NLM
Santana TM, Ogawa LY, Rogero MM, Barroso LP, Castro IA de. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans [Internet]. Atherosclerosis. 2021 ; 331 e251 res. P609.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.768
Vancouver
Santana TM, Ogawa LY, Rogero MM, Barroso LP, Castro IA de. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans [Internet]. Atherosclerosis. 2021 ; 331 e251 res. P609.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.768
Artigo de periodico
Familial hypercholesterolemia and cardiovascular disease in older individuals (2021)
Coutinho, Elaine R; Minami, Marcio H; Rocha, Viviane Z; Bittencourt, Márcio Sommer ; Jannes, Cinthia E; Tada, Mauricio T; Lima, Isabella R; Salgado Filho, Wilson; Chacra, Ana P; Pereira, Alexandre C; Krieger, Jose Eduardo ; Santos, Raul D
Fonte: Atherosclerosis. Unidades: HU, FM
Assuntos: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, IDOSOS, ENVELHECIMENTO, ARTERIOSCLEROSE, COLESTEROL, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTINHO, Elaine R et al. Familial hypercholesterolemia and cardiovascular disease in older individuals. Atherosclerosis, v. 318, p. 32-37, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.12.012. Acesso em: 09 nov. 2024.
APA
Coutinho, E. R., Minami, M. H., Rocha, V. Z., Bittencourt, M. S., Jannes, C. E., Tada, M. T., et al. (2021). Familial hypercholesterolemia and cardiovascular disease in older individuals. Atherosclerosis, 318, 32-37. doi:10.1016/j.atherosclerosis.2020.12.012
NLM
Coutinho ER, Minami MH, Rocha VZ, Bittencourt MS, Jannes CE, Tada MT, Lima IR, Salgado Filho W, Chacra AP, Pereira AC, Krieger JE, Santos RD. Familial hypercholesterolemia and cardiovascular disease in older individuals [Internet]. Atherosclerosis. 2021 ; 318 32-37.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.12.012
Vancouver
Coutinho ER, Minami MH, Rocha VZ, Bittencourt MS, Jannes CE, Tada MT, Lima IR, Salgado Filho W, Chacra AP, Pereira AC, Krieger JE, Santos RD. Familial hypercholesterolemia and cardiovascular disease in older individuals [Internet]. Atherosclerosis. 2021 ; 318 32-37.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.12.012
Artigo de periodico
Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study (2021)
Qiying, Song; Qi, Lu; Sun, Dianjianyi; Zhou, Tao; Li, Xiang; Ma, Hao; Liang, Zhaoxia; Wang, Haijun; Cardoso, Marly Augusto ; Heianza, Yoriko
Fonte: Atherosclerosis. Unidade: FSP
Assuntos: TABAGISMO, DOENÇAS CARDIOVASCULARES, SAÚDE MATERNO-INFANTIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QIYING, Song et al. Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study. Atherosclerosis, v. 328, p. 52-59, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2021.05.009. Acesso em: 09 nov. 2024.
APA
Qiying, S., Qi, L., Sun, D., Zhou, T., Li, X., Ma, H., et al. (2021). Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study. Atherosclerosis, 328, 52-59. doi:10.1016/j.atherosclerosis.2021.05.009
NLM
Qiying S, Qi L, Sun D, Zhou T, Li X, Ma H, Liang Z, Wang H, Cardoso MA, Heianza Y. Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study [Internet]. Atherosclerosis. 2021 ;328 52-59.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.05.009
Vancouver
Qiying S, Qi L, Sun D, Zhou T, Li X, Ma H, Liang Z, Wang H, Cardoso MA, Heianza Y. Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study [Internet]. Atherosclerosis. 2021 ;328 52-59.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.05.009
Trabalho de evento-resumo periodico
Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? (2021)
Pimentel, Mariana Vieira de Mello Barros ; Barroso, Lucia Pereira; Castro, Inar Alves de
Fonte: Atherosclerosis. Nome do evento: Congress European Atherosclerosis Society/EAS. Unidades: IME, FCF
Assuntos: BIOMARCADORES, ESTRESSE OXIDATIVO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Mariana Vieira de Mello Barros e BARROSO, Lucia Pereira e CASTRO, Inar Alves de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease?. Atherosclerosis. Clare: Instituto de Matemática e Estatística, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf. Acesso em: 09 nov. 2024. , 2021
APA
Pimentel, M. V. de M. B., Barroso, L. P., & Castro, I. A. de. (2021). Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? Atherosclerosis. Clare: Instituto de Matemática e Estatística, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
NLM
Pimentel MV de MB, Barroso LP, Castro IA de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? [Internet]. Atherosclerosis. 2021 ; 331 e210 res. P485.[citado 2024 nov. 09 ] Available from: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
Vancouver
Pimentel MV de MB, Barroso LP, Castro IA de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? [Internet]. Atherosclerosis. 2021 ; 331 e210 res. P485.[citado 2024 nov. 09 ] Available from: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
Artigo de periodico
Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) (2020)
Cardoso, Rhanderson; Generoso, Giuliano; Staniak, Henrique L; Foppa, Murilo; Duncan, Bruce B; Pereira, Alexandre C; Blaha, Michael J; Blankstein, Ron; Benseñor, Isabela Judith Martins ; Lotufo, Paulo Andrade
Fonte: Atherosclerosis. Unidade: FM
Assuntos: ESTUDOS LONGITUDINAIS, FATORES DE RISCO, CÁLCIO, VASOS CORONÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Rhanderson et al. Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis, v. 309, p. 8-15, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.07.003. Acesso em: 09 nov. 2024.
APA
Cardoso, R., Generoso, G., Staniak, H. L., Foppa, M., Duncan, B. B., Pereira, A. C., et al. (2020). Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis, 309, 8-15. doi:10.1016/j.atherosclerosis.2020.07.003
NLM
Cardoso R, Generoso G, Staniak HL, Foppa M, Duncan BB, Pereira AC, Blaha MJ, Blankstein R, Benseñor IJM, Lotufo PA. Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) [Internet]. Atherosclerosis. 2020 ; 309 8-15.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.07.003
Vancouver
Cardoso R, Generoso G, Staniak HL, Foppa M, Duncan BB, Pereira AC, Blaha MJ, Blankstein R, Benseñor IJM, Lotufo PA. Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) [Internet]. Atherosclerosis. 2020 ; 309 8-15.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.07.003
Artigo de periodico
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels (2020)
Zheng, Kang H; Kaiser, Yannick; Olden, Casper C. van; Santos Filho, Raul Dias dos ; Dasseux, Jean-Louis; Genest, Jacques; Gaudet, Daniel; Westerink, Jan; Verberne, Hein J
Fonte: Atherosclerosis. Unidade: FM
Assuntos: APOLIPOPROTEÍNAS, COLESTEROL, LIPOPROTEÍNAS HDL, MEIA IDADE, FOSFOLIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZHENG, Kang H et al. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, v. 311, p. 13-19, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.08.004. Acesso em: 09 nov. 2024.
APA
Zheng, K. H., Kaiser, Y., Olden, C. C. van, Santos Filho, R. D. dos, Dasseux, J. -L., Genest, J., et al. (2020). No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, 311, 13-19. doi:10.1016/j.atherosclerosis.2020.08.004
NLM
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004
Vancouver
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004
Artigo de periodico
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes (2020)
Ramin-mangata, Stephane; Wargny, Matthieu; Pichelin, Matthieu; May, Cedric Le; Thedrez, Aurelie; Blanchard, Valentin; Nativel, Brice; Santos, Raul D; Bensenor, Isabela Judith Martins ; Lotufo, Paulo Andrade
Fonte: Atherosclerosis. Unidade: FM
Assuntos: LIPOPROTEÍNAS LDL, ENZIMAS PROTEOLÍTICAS, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, HOMEOSTASE, GLICOSE, FATORES DE RISCO, ELISA, ESTUDOS LONGITUDINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMIN-MANGATA, Stephane et al. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis, v. 293, p. 49-56, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.11.027. Acesso em: 09 nov. 2024.
APA
Ramin-mangata, S., Wargny, M., Pichelin, M., May, C. L., Thedrez, A., Blanchard, V., et al. (2020). Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis, 293, 49-56. doi:10.1016/j.atherosclerosis.2019.11.027
NLM
Ramin-mangata S, Wargny M, Pichelin M, May CL, Thedrez A, Blanchard V, Nativel B, Santos RD, Bensenor IJM, Lotufo PA. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes [Internet]. Atherosclerosis. 2020 ; 293 49-56.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.11.027
Vancouver
Ramin-mangata S, Wargny M, Pichelin M, May CL, Thedrez A, Blanchard V, Nativel B, Santos RD, Bensenor IJM, Lotufo PA. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes [Internet]. Atherosclerosis. 2020 ; 293 49-56.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.11.027
Artigo de periodico
Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study (2020)
Janovsky, Carolina Castro Porto Silva; Generoso, Giuliano; Goulart, Alessandra C; Santos Filho, Raul Dias dos ; Blaha, Michael J; Jones, Steven; Toth, Peter P.; Lotufo, Paulo Andrade ; Bittencourt, Marcio Sommer; Benseñor, Isabela Judith Martins
Fonte: Atherosclerosis. Unidade: FM
Assuntos: COLESTEROL, HIPERTIREOIDISMO, DIAGNÓSTICO, EPIDEMIOLOGIA, MEIA IDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANOVSKY, Carolina Castro Porto Silva et al. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study. Atherosclerosis, v. 312, p. 60-65, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.08.021. Acesso em: 09 nov. 2024.
APA
Janovsky, C. C. P. S., Generoso, G., Goulart, A. C., Santos Filho, R. D. dos, Blaha, M. J., Jones, S., et al. (2020). Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study. Atherosclerosis, 312, 60-65. doi:10.1016/j.atherosclerosis.2020.08.021
NLM
Janovsky CCPS, Generoso G, Goulart AC, Santos Filho RD dos, Blaha MJ, Jones S, Toth PP, Lotufo PA, Bittencourt MS, Benseñor IJM. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study [Internet]. Atherosclerosis. 2020 ; 312 60-65.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.021
Vancouver
Janovsky CCPS, Generoso G, Goulart AC, Santos Filho RD dos, Blaha MJ, Jones S, Toth PP, Lotufo PA, Bittencourt MS, Benseñor IJM. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study [Internet]. Atherosclerosis. 2020 ; 312 60-65.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.021
Artigo de periodico-carta/editorial
Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? (2020)
Santos Filho, Raul Dias dos
Fonte: Atherosclerosis. Unidade: FM
Assuntos: ARTERIOSCLEROSE, CALCIFICAÇÃO FISIOLÓGICA, VASOS CORONÁRIOS, CORONARIOPATIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels?. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.12.019. Acesso em: 09 nov. 2024. , 2020
APA
Santos Filho, R. D. dos. (2020). Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2019.12.019
NLM
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.12.019
Vancouver
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.12.019
Artigo de periodico-carta/editorial
Very high LDL cholesterol: the power of zero passes another test [Editorial] (2020)
Bittencourt, Márcio Sommer; Nasir, Khurram; Santos, Raul D; Al-Mallah, Mouaz H
Fonte: Atherosclerosis. Unidade: HU
Assuntos: HIPERLIPIDEMIA, CÁLCIO, FATORES DE RISCO, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer et al. Very high LDL cholesterol: the power of zero passes another test [Editorial]. Atherosclerosis. Amsterdam: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.11.019. Acesso em: 09 nov. 2024. , 2020
APA
Bittencourt, M. S., Nasir, K., Santos, R. D., & Al-Mallah, M. H. (2020). Very high LDL cholesterol: the power of zero passes another test [Editorial]. Atherosclerosis. Amsterdam: Hospital Universitário, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2019.11.019
NLM
Bittencourt MS, Nasir K, Santos RD, Al-Mallah MH. Very high LDL cholesterol: the power of zero passes another test [Editorial] [Internet]. Atherosclerosis. 2020 ; 292 207-208.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.11.019
Vancouver
Bittencourt MS, Nasir K, Santos RD, Al-Mallah MH. Very high LDL cholesterol: the power of zero passes another test [Editorial] [Internet]. Atherosclerosis. 2020 ; 292 207-208.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.11.019
Artigo de periodico
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia (2019)
Reeskamp, Laurens F; Kastelein, John J. P; Moriarty, Patrick M; Duell, P. Barton; Catapano, Alberico L; Santos Filho, Raul Dias dos; Ballantyne, Christie M
Fonte: Atherosclerosis. Unidade: FM
Assuntos: HIPERCOLESTEROLEMIA, OLIGONUCLEOTÍDEOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REESKAMP, Laurens F et al. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 280, p. 109-117, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.11.017. Acesso em: 09 nov. 2024.
APA
Reeskamp, L. F., Kastelein, J. J. P., Moriarty, P. M., Duell, P. B., Catapano, A. L., Santos Filho, R. D. dos, & Ballantyne, C. M. (2019). Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 280, 109-117. doi:10.1016/j.atherosclerosis.2018.11.017
NLM
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017
Vancouver
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017
Trabalho de evento-resumo periodico
Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle (2019)
Pinto, Paula Ramos ; Bianco, Vanessa Del; Bochi, Ana Paula Garcia; Ferreira, Guilherme da Silva; Trevisani, M. da Silva; Rodrigues, L. Gomes; Nakandakare, Edna Regina; Okamoto, Maristela Mitiko; Machado, Ubiratan Fabres ; Catanozi, Sergio ; Passarelli, Marisa
Fonte: Atherosclerosis. Nome do evento: 87th European Atherosclerosis Society (EAS) Congress. Maastricht, Países Baixos. Unidades: FM, ICB
Assuntos: FISIOLOGIA, RESISTÊNCIA À INSULINA, EXERCÍCIO FÍSICO, TREINAMENTO AERÓBIO, TREINAMENTO FÍSICO, SÓDIO, MÚSCULO ESQUELÉTICO, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Paula Ramos et al. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle. Atherosclerosis. Amsterdan: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.06.273. Acesso em: 09 nov. 2024. , 2019
APA
Pinto, P. R., Bianco, V. D., Bochi, A. P. G., Ferreira, G. da S., Trevisani, M. da S., Rodrigues, L. G., et al. (2019). Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle. Atherosclerosis. Amsterdan: Elsevier. doi:10.1016/j.atherosclerosis.2019.06.273
NLM
Pinto PR, Bianco VD, Bochi APG, Ferreira G da S, Trevisani M da S, Rodrigues LG, Nakandakare ER, Okamoto MM, Machado UF, Catanozi S, Passarelli M. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle [Internet]. Atherosclerosis. 2019 ; 287 e94.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.06.273
Vancouver
Pinto PR, Bianco VD, Bochi APG, Ferreira G da S, Trevisani M da S, Rodrigues LG, Nakandakare ER, Okamoto MM, Machado UF, Catanozi S, Passarelli M. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle [Internet]. Atherosclerosis. 2019 ; 287 e94.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.06.273
Artigo de periodico
Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil (2019)
Harada, Paulo H; Benseñor, Isabela M; Drager, Luciano F; Goulart, Alessandra Carvalho; Mill, José G; Lotufo, Paulo Andrade
Fonte: Atherosclerosis. Unidades: FM, HU
Assuntos: FÍGADO GORDUROSO, AORTA, DOENÇAS CARDIOVASCULARES, OBESIDADE, GRUPOS ÉTNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARADA, Paulo H et al. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil. Atherosclerosis, v. 284, p. 59-65, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.02.005. Acesso em: 09 nov. 2024.
APA
Harada, P. H., Benseñor, I. M., Drager, L. F., Goulart, A. C., Mill, J. G., & Lotufo, P. A. (2019). Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil. Atherosclerosis, 284, 59-65. doi:10.1016/j.atherosclerosis.2019.02.005
NLM
Harada PH, Benseñor IM, Drager LF, Goulart AC, Mill JG, Lotufo PA. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil [Internet]. Atherosclerosis. 2019 ; 284 59-65.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.02.005
Vancouver
Harada PH, Benseñor IM, Drager LF, Goulart AC, Mill JG, Lotufo PA. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil [Internet]. Atherosclerosis. 2019 ; 284 59-65.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.02.005
Artigo de periodico
In memoriam: Dr. Akira Yamamoto 1932-2019 (2019)
Matsuzawa, Yuji; Yamashita, Shizuya; Santos Filho, Raul Dias dos; Libby, Peter
Fonte: Atherosclerosis. Unidade: FM
Assuntos: ESTATINAS, BIOGRAFIAS, MEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATSUZAWA, Yuji et al. In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, v. 283, p. 120-120, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.01.028. Acesso em: 09 nov. 2024.
APA
Matsuzawa, Y., Yamashita, S., Santos Filho, R. D. dos, & Libby, P. (2019). In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, 283, 120-120. doi:10.1016/j.atherosclerosis.2019.01.028
NLM
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.028
Vancouver
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.028
Artigo de periodico
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps (2019)
Santos Filho, Raul Dias dos; Valenti, Luca; Romeo, Stefano
Fonte: Atherosclerosis. Unidade: FM
Assuntos: FÍGADO GORDUROSO, HEPATOPATIAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos e VALENTI, Luca e ROMEO, Stefano. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis, v. 282, p. 110-120, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.01.029. Acesso em: 09 nov. 2024.
APA
Santos Filho, R. D. dos, Valenti, L., & Romeo, S. (2019). Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis, 282, 110-120. doi:10.1016/j.atherosclerosis.2019.01.029
NLM
Santos Filho RD dos, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps [Internet]. Atherosclerosis. 2019 ; 282 110-120.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.029
Vancouver
Santos Filho RD dos, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps [Internet]. Atherosclerosis. 2019 ; 282 110-120.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.029

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos